Brand Name | Status | Last Update |
---|---|---|
ferrlecit | New Drug Application | 2025-06-06 |
infed | New Drug Application | 2024-10-14 |
iron dextran | New Drug Application | 2025-01-08 |
venofer | New Drug Application | 2022-07-25 |
venofer (iron sucrose) | New Drug Application | 2024-04-19 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Ferric Oxyhydroxide, Velphoro, Vifor Fresenius | |||
10624855 | 2034-11-26 | DP | |
11234938 | 2034-11-26 | DP | |
11446252 | 2034-11-26 | DP | |
9561251 | 2030-01-23 | DP | U-1468 |
10682376 | 2028-11-13 | DP | |
10695367 | 2028-11-13 | DP | |
10925896 | 2028-11-13 | DP | |
10925897 | 2028-11-13 | DP | |
10933090 | 2028-11-13 | DP | |
11013761 | 2028-11-13 | DP | |
11013762 | 2028-11-13 | DP |
Code | Description |
---|---|
J1750 | Injection, iron dextran, 50 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Iron overload | D019190 | — | — | 2 | 17 | 7 | 14 | 6 | 44 |
Thalassemia | D013789 | EFO_1001996 | D56 | 1 | 9 | 4 | 9 | 2 | 25 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 11 | — | 6 | 3 | 20 |
Preleukemia | D011289 | — | — | — | 9 | — | 6 | 3 | 18 |
Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | 1 | 6 | 3 | 5 | 1 | 16 |
Syndrome | D013577 | — | — | — | 7 | — | 6 | 2 | 15 |
Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 5 | 1 | 5 | 2 | 14 |
Hemochromatosis | D006432 | EFO_1000642 | E83.11 | 1 | 6 | 2 | 4 | 1 | 13 |
Hemosiderosis | D006486 | — | — | 1 | 6 | 2 | 4 | 1 | 13 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | 3 | 2 | 1 | 3 | 9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 1 | 1 | 1 | — | — | 2 |
Myeloid leukemia | D007951 | — | C92 | 1 | 1 | 1 | — | — | 2 |
Porphyria cutanea tarda | D017119 | — | E80.1 | — | — | 1 | — | — | 1 |
Erythropoietic porphyria | D017092 | — | — | — | — | 1 | — | — | 1 |
Porphyrias | D011164 | EFO_0000665 | — | — | — | 1 | — | — | 1 |
Hepatic porphyrias | D017094 | — | — | — | — | 1 | — | — | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | — | — | 1 | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | 1 | — | — | 1 |
Philadelphia chromosome | D010677 | — | — | — | — | 1 | — | — | 1 |
Hepatitis b | D006509 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mucormycosis | D009091 | EFO_0007380 | B46.5 | — | 1 | — | — | — | 1 |
Zygomycosis | D020096 | — | B46 | — | 1 | — | — | — | 1 |
Hemolytic anemia | D000743 | — | D55-D59 | — | 1 | — | — | — | 1 |
Fanconi anemia | D005199 | Orphanet_84 | D61.03 | — | 1 | — | — | — | 1 |
Fanconi syndrome | D005198 | — | — | — | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | — | 1 |
Iron-deficiency anemia | D018798 | — | D50 | 1 | — | — | — | — | 1 |
Iron deficiencies | D000090463 | — | E61.1 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | — | — | — | 1 | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | — | — | 1 | 1 |
Fatty liver | D005234 | EFO_0003934 | — | — | — | — | — | 1 | 1 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | — | — | — | — | 1 | 1 |
Drug common name | Iron dextran |
INN | — |
Description | Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 10028-22-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1201544 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |